Home/Filings/4/0001144204-17-002903
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001144204-17-002903

CIK 0000810509operating

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 3:44 PM ET

Size

7.0 KB

Accession

0001144204-17-002903

Insider Transaction Report

Form 4
Period: 2017-01-17
Transactions
  • Exercise of In-Money

    Warrants (Right to Buy)

    2017-01-175,411,8500 total
    Exercise: $0.01From: 2016-10-17Exp: 2035-08-20Common Stock (5,411,850 underlying)
  • Exercise of In-Money

    NAVB Common Stock, $.001 par value

    2017-01-17$0.01/sh+5,411,850$54,1195,815,002 total
Footnotes (1)
  • [F1]Series LL warrants exercised in exchange for issuance of common stock.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 3:44 PM ET
Size
7.0 KB